Abstract. The repeated replication of cells shortens telomeres, culminating in their instability, after which most cells cease to replicate and die. However, a small fraction of the cells become immortalized by maintaining telomeres with activated telomerase activity. It has been proposed that WRN helicase encoded by the WRN gene, the causative gene of Werner syndrome (WS), is required for immortalization by the telomeric crisis pathway (TCP) in a system that uses lymphoblastoid cell lines transformed by the Epstein-Barr virus. Taken together, these characteristics indicate that WRN helicase is also required for the immortalization of epithelial cells by TCP and consequent carcinogenesis, suggesting that the tumorigenesis of epithelial cells by TCP is suppressed in WS lacking the WRN helicase function. Notably, in WS the pathway of alternative lengthening of telomeres without activation of telomerase activity has been suggested to be involved in immortalization and tumorigenesis. This factor is consistent with the abundance of non-epithelial cancers in WS in that the ratio of epithelial to non-epithelial cancers is approximately 1:1 in WS patients compared to 10:1 in the general population. A hypothetical scheme showing the role of WRN helicase in immortalization by means of the supposed 'breakage-fusionbridge cycle' of chromosomes at telomeric crisis is described. 
Introduction
The Werner syndrome (WS) is an autosomal recessive disorder causing symptoms of premature aging (1) . The causative gene of WS is the WRN gene encoding for WRN protein, a DNA helicase (2) . Another characteristic feature of this disorder is a much higher incidence of rare cancers (3) . Non-epithelial tumors, including soft-tissue sarcoma and benign meningioma, are associated with WS, as shown by 124 case reports of neoplasia of WS patients from Japan, and 34 case reports from outside Japan between 1939 and August 1995. Notably, the ratio of epithelial to non-epithelial cancers was approximately 1:1 in WS patients compared to 10:1 in the general population. Two telomere maintenance mechanisms, telomerase activation (4) and alternative lengthening of telomeres (ALT) (5, 6) exist. In human tumors of the general population over 80% of carcinomas maintain telomeres by telomerase activation, whereas various types of sarcomas elongate telomeres by means of ALT in the absence of telomerase activity (7). In tumors in WS patients, however, evidence has shown that the telomerase activation pathway by telomeric crisis is blocked, while the ALT pathway is enhanced (8-10), supporting the high incidence of rare cancers in WS.
Role of WRN gene in immortalization by means of telomeric crisis pathway
The repeated replication of cells shortens telomeres, culminating in their instability, after which most cells cease to replicate and die. However, a small fraction of the cells become immortalized by maintaining telomeres with activated telomerase activity, known as the telomeric crisis pathway (TCP) (11) (12) (13) . We showed that lymphoblastoid cell lines (LCLs) transformed by the Epstein-Barr virus generate immortalized cell lines by means of TCP (13 (8, 14) . These results indicated that WRN helicase is crucial to immortalization by TCP (8, 9) . These factors together indicate that WRN helicase is also required for the immortalization of epithelial cells by TCP and consequent carcinogenesis, suggesting that the tumorigenesis of epithelial cells by TCP is suppressed in WS patients lacking the WRN helicase function. Notably, the ALT pathway in the absence of telomerase activity in WS has been indicated to be involved in the immortalization and tumorigenesis of non-epithelial tumors (10) . These considerations were consistent with the abovementioned abundance of non-epithelial cancers in WS.
Role of WRN gene in breakage-fusion-bridge cycle at telomeric crisis pathway
In this review, we present and discuss a hypothetical scheme showing the role of WRN helicase in immortalization by means of the supposed 'breakage-fusion-bridge cycle' of chromosomes at telomeric crisis proposed by Ishikawa (11) . When two chromosomes lose telomeric function by shortening (Fig. 1A and B) they fuse, resulting in a dicentric chromosome (Fig. 1C) . When the dicentric chromosome is segregated towards two daughter cells during the M phase, two spindles from each of the two daughter cells may attach to each of the two centromeres, leading to the chromosome being pulled apart (Fig. 1D) . Thus, the newly formed ends of the chromosome are non-telomeric. Abnormal cells with nontelomeric chromosomes probably do not survive unless the non-telomeric end is capped again with telomeres.
The de novo addition of telomeres to non-telomeric ends has been reported (15) . For instance, during programmed chromosomal healing, telomerase adds telomeric repeats directly to non-telomeric sequences in the protozoan Tetrahymena, forming de novo telomeres. Therefore, to add a telomere to a non-telomeric end, initial activation of the telomerase is required ( Fig. 1D and E) . Such activation may occur when the repression of the human telomerase reverse transcriptase (hTERT) gene is released. Alu-elements and other humanspecific repetitive sequences exist abundantly around the hTERT gene, probably forming a repressed chromatin structure in human cells. In this regard, it has been indicated that chromosomal translocations allow the promoter of hTERT to escape the repressive chromatin environment at telomeric crisis (reviewed in 16). One characteristic of immortalization by telomere crisis in LCLs is that abnormal chromosomes occur simultaneously with activation of the telomerase, and all 11 immortalized LCLs were found to possess abnormal chromosomes (13) . Cells of each immortalized LCL share a set of abnormal chromosomes, indicating a clonal origin of LCL cells. However, abnormal chromosomes are not shared among LCLs. During the telomeric crisis towards immortalization a series of marked changes should occur accompanied by the reorganization of chromosomes. These changes may include epigenetic ones around telomeric regions as observed during the generation of human pluripotent stem cells (17) .
Such epigenetic changes may contribute to modification of the hTERT gene region to activate telomerase.
The above-mentioned process of immortalization by TCP is summarized in Fig. 1 . WRN helicase may play at least two mutually compatible roles in immortalization by TCP. First, under the supposed epigenetic changes WRN helicase may unwind the repressed state of chromatin DNA that is rich in repetitive elements and resistant to nuclease digestion, leading to modification and activation of the promoter region of the hTERT gene by translocation (reviewed in 16) (Fig. 1D) . Second, in the telomerase-mediated de novo addition of telomeres to non-telomeric sequences (Fig. 1E) , exonuclease activity of WRN helicase may also be involved in this process to trim the 3' end to expose a favorable sequence as a primer for adding a telomere to the non-telomeric end (15) . In this regard, a particular sequence, such as GGGAT in the case of human, is predominantly added by telomerase onto the 3' end of nontelomeric primers. Among the five RecQ helicases, only WRN helicase has exonuclease activity (reviewed in 18), and the fact that the remaining four RecQ helicases cannot complement the function of WRN helicase supports the role of exonuclease activity of WRN helicase in the immortalization by TCP.
Conclusion
In this review, we proposed a hypothesis regarding the role of WRN helicase in immortalization by means of TCP, indicating that WRN helicase may play an important role in the 'breakage-fusion-bridge cycle'. This hypothesis may lead to future studies at molecular levels in order to elucidate the role of WRN helicase in immortalization and tumorigenesis. 
